Eli Lilly sues vendors for selling unauthorized tirzepatide amid resolved shortages. Lawsuits target vendors offering ...
The lawsuit singles out Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine for either offering research-grade meds ...
Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...
In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...
The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, are the first related to ...
Want to try Ozempic for your weight loss journey? Discover how to get it, what to expect, and alternatives from brands like ...
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...
Shortages of tirzepatide, sold as a diabetes drug (Mounjaro) and a weight-loss medication (Zepbound), have fueled demand for compounding pharmacies to make their own versions of the medicine, which ...